Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial Cystitis: a Randomized, Double-blind, Placebo-controlled Study

NCT05912946 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT05912946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05912946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial Cystitis: a Randomized, Double-blind, Placebo-controlled Study
Lead sponsor
West China Hospital
Phase
Phase 2/3
Overall status
Unknown status
Start date
October 15, 2023
Completion date
October 15, 2024
Enrollment
129 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial cystitis